Phoenix Financial’s Halozyme HALO Stock Holding History

Phoenix Financial’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-26,362	Closed	-$1.04M	–	399
2021 Q3	$1.04M	Sell	26,362 -9,638	-27%	-$403K	0.02%	269
2021 Q2	$1.65M	Buy	+36,000	New	+$1.59M	0.03%	233

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Phoenix Financial's HALO Position: Q4 2021 in Review

Phoenix Financial sold out of Halozyme (HALO) in Q4 2021, closing a stake of 26,362 shares — an estimated $1.04M sold.

Phoenix Financial first reported a position in HALO in Q2 2021 and held it in 2 quarters. The position peaked at $1.65M in Q2 2021. 324 funds tracked by Wall St. Rank hold HALO as of Q4 2021.

Phoenix Financial reported no remaining Halozyme position as of Q4 2021 after selling out during the quarter.
Phoenix Financial sold 26,362 Halozyme shares in Q4 2021, an estimated $1.04M.
Phoenix Financial first reported a position in Halozyme in Q2 2021 and held it in 2 quarters.
Phoenix Financial's Halozyme position peaked at $1.65M in Q2 2021.
324 funds tracked by Wall St. Rank held Halozyme as of Q4 2021.

Based on Phoenix Financial's 13F filing for Q4 2021, filed 7 Feb 2022.